In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Women with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when ...

As Ohio cuts off state employees' coverage of medications for weight loss, a lawmaker who has benefited from the drugs wants to bring them back.

A new expert consensus statement issued by the American College of Cardiology said that cardiologists should “embrace” new weight-loss medications for patients with obesity, TCTMD reported June 25.

A lower-sodium Dietary Approaches to Stop Hypertension-style diet was associated with clinically meaningful BP reduction in ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

Greater weight loss and more diabetes remission were seen among adult women with overweight, obesity, and T2D.

All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.

Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...

Innovent Biologics presents results from DREAMS-1 phase 3 study of mazdutide in Chinese adults with T2D at ADA Scientific Sessions: San Francisco Thursday, June 26, 2025, 14:00 Hr ...

BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...